Li, Q., Zhang, D., Chen, X., He, L., Li, T., Xu, X., & Li, M. (2015). Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer. Scientific reports, 5(1), 16082. https://doi.org/10.1038/srep16082
Chicago Style (17th ed.) CitationLi, Qiong, Daoxiang Zhang, Xiaoying Chen, Lei He, Tianming Li, Xiaoping Xu, and Min Li. "Nuclear PKM2 Contributes to Gefitinib Resistance via Upregulation of STAT3 Activation in Colorectal Cancer." Scientific Reports 5, no. 1 (2015): 16082. https://doi.org/10.1038/srep16082.
MLA (9th ed.) CitationLi, Qiong, et al. "Nuclear PKM2 Contributes to Gefitinib Resistance via Upregulation of STAT3 Activation in Colorectal Cancer." Scientific Reports, vol. 5, no. 1, 2015, p. 16082, https://doi.org/10.1038/srep16082.